Status:
COMPLETED
Fractionated Stereotactic Radiotherapy in Patients With Acromegaly
Lead Sponsor:
Rigshospitalet, Denmark
Conditions:
Acromegaly
Eligibility:
All Genders
18+ years
Brief Summary
Hypothesis: Fractionated stereotactic radiotherapy is a safe therapy for treatment of patients with acromegaly in terms of both tumour control and biochemical remission
Detailed Description
An audit was done on 34 patients with acromegaly (consecutive cohorte) treated with fractionated stereotactic radiotherapy in Rigshospitalet/National University Hospital, Copenhagen, Denmark. All pati...
Eligibility Criteria
Inclusion
- adults active acromegaly pituitary tumour on MRI biochemical activity -
Exclusion
- pregnancy no visible tumour on MRI
- \-
Key Trial Info
Start Date :
January 1 2002
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
January 1 2008
Estimated Enrollment :
34 Patients enrolled
Trial Details
Trial ID
NCT00934271
Start Date
January 1 2002
End Date
January 1 2008
Last Update
October 28 2014
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
National University Hospital, Department of Medical Endocrinology
Copenhagen, Denmark, DK-2100